SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
QumulusAI, Inc. shareholders approved and adopted the 2026 Equity Incentive Plan, which permits grants of stock options, restricted stock units, performance awards, and other equity-based compensation to employees, directors, and consultants, with an initial share pool of 4,770,000 shares and annual increases.
View raw filing on EDGAR →The disclosure centers on a performance-based restricted stock unit (PSU) award granted to CEO Sridhar Ramaswamy on July 15, 2026, consisting of 1,000,000 shares with stock price milestones designed to create up to $100 billion in stockholder value. This is a compensatory arrangement for a named executive officer disclosed under Item 5.02(e), distinct from an appointment or departure. The award's material terms—including vesting conditions, performance periods, and clawback provisions—are detailed, making this a significant executive compensation disclosure material to investors assessing executive incentive alignment and retention strategies.
View raw filing on EDGAR →The disclosure centers on an updated offer letter for David Vetter as Chief Legal Officer, detailing compensatory arrangements including a $670,000 annual base salary, 100% bonus target, and $1.5 million in equity awards (60% time-based, 40% performance-based). While the filing is under Item 5.02(e), the principal disclosed action is the modification of executive compensation terms, not a departure or appointment, making exec_compensation the most salient classification.
View raw filing on EDGAR →Ryan Steelberg, the President, CEO, and Chairman, voluntarily reduced his salary by 50% from $665,000 to $332,500 effective July 14, 2026. This is a material modification to executive compensation arrangements disclosed under Item 8.01. While the reduction is voluntary and supportive of cost initiatives, it represents a significant change to a named executive's compensation that would affect investor assessment of the company's financial condition and leadership commitment.
View raw filing on EDGAR →The disclosure centers on an amendment to a Director Services Agreement with William P. Foley II that modifies his compensatory arrangement by deleting a provision permitting him to sell 50% of his shares back to Cannae at defined prices. This is a material modification to an executive's equity-related compensation arrangement, triggered by the closing of the Brasada Ranch sale. While the transaction itself is M&A-related, the Item 5.02 disclosure focuses on the compensatory arrangement amendment rather than the sale itself.
View raw filing on EDGAR →This exhibit is the "Second Amended and Restated 2019 Share Incentive Plan" for NetEase, Inc., which establishes the framework for granting Restricted Share Units and Options to Eligible Participants (Employees, Directors, and Consultants). The document sets forth the purposes, definitions, and governance structure for equity compensation awards. As a material amendment to the company's equity incentive plan affecting director and officer compensation arrangements, this constitutes an executive compensation disclosure under the taxonomy.
View raw filing on EDGAR →TriCo Bancshares approved a special one-time transaction bonus of $2,500,000 to Richard P. Smith, TriCo's Chairman, President and CEO, contingent on continued employment through merger closing.
View raw filing on EDGAR →This announcement discloses the grant of 1,255,122 restricted share units (RSUs) to 47 employees on July 15, 2026, pursuant to the 2025 Share Incentive Scheme. The disclosure details the vesting schedules, terms, and conditions of the equity awards. Although the grantees are employees rather than named executives, this is a material compensatory arrangement involving equity grants that would affect investor assessment of the company's capital structure and employee incentive practices. The RSUs represent approximately 0.07% of issued shares and are subject to service-based vesting conditions over multiple years.
View raw filing on EDGAR →The disclosure centers on compensatory arrangements for a departing officer: a severance agreement providing $365,775.12 in severance, COBRA premium coverage, conditional change-in-control benefits (18 months base salary plus 2026 bonus target), and a consulting agreement at $1,000/hour. While Valerie Barnett's departure as Chief Legal Officer occurred on June 29, 2026, the material 8-K event filed on July 15 focuses on the severance and consulting compensation arrangements negotiated on July 9, 2026, making this primarily an exec_compensation disclosure under Item 5.02(e).
View raw filing on EDGAR →The 6-K discloses a grant of 14,060 warrants to employees on July 14, 2026, with an exercise price of $265.57 per share and a four-year vesting schedule (25% at one year, then 1/36th monthly). This is a compensatory arrangement for named executives and employees under the company's Articles of Association, materially affecting equity incentive arrangements and shareholder dilution.
View raw filing on EDGAR →This exhibit is an Amended and Restated 2012 Share Option Plan for PolyPid Ltd., which establishes the terms, administration, and mechanics of equity compensation for employees, officers, directors, and service providers. The document sets forth vesting schedules, exercise prices, and other material terms of option grants. As a plan amendment affecting compensatory arrangements for multiple classes of participants, this constitutes a disclosure of executive and employee compensation arrangements that would be material to a reasonable investor's assessment of the company's capital structure and incentive practices.
View raw filing on EDGAR →The filing discloses compensatory arrangements for three named executives: (1) a discretionary equity award of 50,000 RSUs to the Chief Operating Officer (Amaree Vichairattanawong), fully vested on grant date July 10, 2026; and (2) option awards to CEO Justin Kenna (1,045,712 shares) and CFO Michael Munoz (301,249 shares), both granted July 10, 2026 with 62.5% vesting immediately and 37.5% vesting one year later. The Item 5.02(e) disclosure centers on these equity grants and compensatory arrangements rather than any departure or appointment.
View raw filing on EDGAR →The disclosure centers on the Compensation Committee's amendment to the 2026 Inducement Stock Plan, reducing authorized shares from 2,000,000 to 1,538,000. This is a compensatory arrangement amendment affecting equity grants available for new and returning employees, which falls squarely within exec_compensation under Item 5.02(e). While the amendment reduces rather than expands the pool, it materially affects the compensation framework and equity incentive structure available to officers and employees.
View raw filing on EDGAR →Van A. Dukeman's employment term as CEO was extended through July 1, 2029, with a material compensatory arrangement consisting of a one-time retention award of restricted stock units valued at $2,067,749.88 vesting on July 1, 2029, plus enhanced severance and benefit protections upon qualifying termination.
View raw filing on EDGAR →The filing discloses a change in control agreement entered into with Bradley M. Kool, Executive Vice President and Chief Financial Officer, on July 8, 2026. The agreement specifies severance arrangements (three times base salary plus bonus, COBRA reimbursement for 18 months) and renewal terms tied to board performance evaluations. This is a compensatory arrangement for a named executive officer that would materially affect investor assessment of the company's financial obligations and executive incentives.
View raw filing on EDGAR →The filing discloses compensatory arrangements for two named executives: Christopher V. Vitale (CEO) received a $178,000 cash bonus and 8,700 restricted shares vesting over three years, while Adrienne M. Uleau (CFO) received a $64,000 cash bonus and 2,250 restricted shares on the same schedule. Additionally, the Company approved salary increases for both executives effective July 27, 2026 ($395,000 for Vitale and $205,000 for Uleau). These are classic equity grants and compensation plan amendments under Item 5.02(e).
View raw filing on EDGAR →The disclosure centers on a revised letter agreement with CEO Stephen Willard that amends his compensatory arrangements, including removal of base salary deferral, establishment of an annual cash bonus program (45% target), modification of severance and change-of-control benefits, and acceleration of equity vesting from four years to three years. This is a material modification of executive compensation terms, not a departure or appointment.
View raw filing on EDGAR →The filing discloses board approval on July 10, 2026 of restricted stock unit (RSU) awards to directors and officers, including CEO Vuong Trieu (2,000 RSUs), Chief Medical Officer Anthony Maida (1,500 RSUs), and other named executives. The RSUs are contingent equity compensation subject to performance and time-based vesting tied to uplisting onto a national stock exchange by June 30, 2027. This is a compensatory arrangement for named executives and directors, squarely within Item 5.02(e) disclosure requirements.
View raw filing on EDGAR →The disclosure centers on an amendment to the Executive Agreement of Lloyd A. Hajdik, the President and CEO, that restructures his severance benefits payable upon qualifying termination events. This is a compensatory arrangement modification affecting a named executive officer's severance terms, which falls squarely within exec_compensation rather than exec_departure (no departure occurred) or exec_appointment (no new role taken).
View raw filing on EDGAR →The 6-K discloses one-time special discretionary bonus awards to two directors (Mr. Lee Seng Chi, chairman and CEO, and Mr. Thien Chiet Chai, director) satisfied by issuance of Class B shares totaling 50,000 shares valued at US$100,000. This is a compensatory arrangement for named executives and constitutes a material disclosure of equity compensation that would affect a reasonable investor's assessment of executive remuneration and potential dilution.
View raw filing on EDGAR →This exhibit is Polyrizon's Compensation Policy for Executive Officers and Directors, adopted on July 13, 2026, pursuant to Israeli Companies Law requirements. It comprehensively sets forth compensation instruments (base salary, benefits, cash bonuses, equity awards, change-of-control provisions, and termination terms), performance objectives, bonus formulas, equity vesting requirements, and clawback provisions. The policy governs compensation arrangements approved after its adoption date and applies for three years unless amended. This is a material disclosure of compensatory arrangements for executive officers and directors that would affect a reasonable investor's assessment of the company's governance and executive incentive structure.
View raw filing on EDGAR →This announcement updates the grant of RSUs (Restricted Stock Units) under the 2021 and 2022 RSU Schemes and options under the Post IPO Share Option Scheme. The disclosure concerns equity compensation awards to executives and employees, which falls squarely within executive compensation. The material correction of the AGM date (May 19, 2025 vs. May 20, 2026) clarifies the authorization basis for these equity grants, making this a material disclosure affecting investor understanding of executive incentive arrangements.
View raw filing on EDGAR →Compass Diversified Holdings entered into a Ninth Amended and Restated Management Services Agreement that materially restructures the external manager's compensation, reducing the base management fee from 2.00% to a tiered structure of 1.25%-1.0% of Adjusted Net Assets and replacing the incentive fee with Share Alignment and Performance-Based Awards tied to TSR and EBITDA metrics. The amendment is expected to reduce total 2027 management fees by approximately $19–22 million while introducing ownership guidelines and clawback protections to strengthen shareholder alignment.
View raw filing on EDGAR →The filing discloses a new employment agreement with Tyler Luck (CEO) executed on June 28, 2026, detailing comprehensive compensatory arrangements including base salary of $360,000, one-time payments totaling $275,000, a non-qualified stock option grant of 100,000 shares with a four-year vesting schedule, and performance-based compensation tied to Russell 1000 inclusion, patent licensing revenue, and market capitalization milestones. While the agreement also establishes employment terms and duration, the substantive disclosure centers on the compensation structure and equity grants, making this primarily an exec_compensation event under Item 5.02(e).
View raw filing on EDGAR →Shareholders approved a 2026 Amendment to the Company's 2023 Omnibus Incentive Compensation Plan at the Annual Meeting, which establishes the framework for granting equity awards (options, restricted stock, RSUs, PSUs, and other stock-based awards) to employees, officers, consultants, and non-employee directors.
View raw filing on EDGAR →The disclosure centers on the Compensation Committee's approval on July 11, 2026 of the 2026 Long Term Incentive Program and 2026 Short Term Incentive Program for named executive officers. The filing details equity awards (RSUs and PSUs with specific vesting and performance metrics) and cash bonus opportunities for Mark Phelan, Scott Levin, and Brett Summerer. This is a classic compensatory arrangement disclosure under Item 5.02(e), material to investors assessing executive incentive structures and retention.
View raw filing on EDGAR →The disclosure centers on an amendment to William Greenman's employment agreement establishing compensatory terms for his new role as Executive Chairman, including a $500,000 annual base salary, 80% target cash bonus for 2026, and COBRA premium reimbursement. While the role transition itself occurred on July 1, 2026, the material disclosure here is the contractual compensation arrangement amendment executed July 6, 2026, which is the substance of the Item 5.02(e) filing.
View raw filing on EDGAR →This exhibit is the Third Amended and Restated Equity Incentive Plan for Lithium Argentina AG, which establishes the framework for granting equity awards (Options, Deferred Share Units, and Restricted Share Rights) to employees and directors. The plan document itself constitutes a disclosure of compensatory arrangements for named executives and directors, falling squarely within the exec_compensation category. The materiality is high because equity incentive plans are fundamental governance and compensation instruments that affect executive retention, incentive alignment, and shareholder dilution.
View raw filing on EDGAR →The announcement discloses pro-rata adjustments to outstanding share options and RSUs granted under the 2021 Plan following a share subdivision effective July 10, 2026. While the primary event is the share subdivision itself (a capital structure change), the exhibit's substantive focus is on the mechanical adjustments to executive and employee equity compensation instruments—exercise prices, share counts, and vesting arrangements. The detailed tables showing adjustments for named directors (Yifan Li, Kai Sun, Shaoqing Xiang, Cailian Yang, Zhang Yi, Ren Jia, Hui Wang) and employees reflect a compensatory arrangement modification required by the subdivision. This falls within the scope of exec_compensation as a disclosure of adjustments to equity grants and compensation plan mechanics.
View raw filing on EDGAR →Stockholders approved the Amended and Restated 2023 Stock Incentive Plan, which increased authorized shares by 1,000,000 and added provisions for performance-based awards to officers and directors.
View raw filing on EDGAR →This exhibit is an Amended and Restated Share Compensation Plan for Franco-Nevada Corporation, establishing the framework for awards of Restricted Share Units and Options to eligible persons (officers, employees, directors, and consultants). The document discloses compensatory arrangements including vesting criteria, deferral elections, and plan administration. This constitutes a material disclosure of executive and employee compensation arrangements that would affect a reasonable investor's assessment of the registrant's compensation practices and equity obligations.
View raw filing on EDGAR →The Board approved an amendment to the Corporate Executive Officer Compensation and Benefits Continuation Policy on July 7, 2026, modifying severance and supplemental compensation arrangements for covered executives in connection with a change in control. The amendment reduces benefits by capping supplemental salary payments at 24 months and revises the calculation methodology for supplemental compensation related to forgone bonuses. This is a direct modification of compensatory arrangements for officers and is material to investors assessing executive cost obligations and change-of-control liabilities.
View raw filing on EDGAR →The Board granted restricted stock units (RSUs) to executive officers (Shao-Lee Lin, Sumita Ray, Michael Meluzio) and non-employee directors on July 9, 2026, pursuant to the 2026 Stock Incentive Plan approved at the most recent shareholder meeting.
View raw filing on EDGAR →HeartSciences amended the employment agreement of Danielle Watson (CFO) and granted her 25,000 RSUs in connection with a pending merger. The amendments modify severance provisions (six months base salary, COBRA, 100% acceleration of unvested equity), add discretionary performance bonus eligibility, and establish vesting conditions tied to the merger closing and continued employment.
View raw filing on EDGAR →KBR amended and restated severance and change-in-control agreements for six named executive officers, including the CEO and CFO. The amendments materially enhance severance benefits (increasing the cash severance multiple for non-CEO officers from 1.0x to 1.5x base salary plus target bonus), expand the definition of "Good Reason" to include material diminution of compensation or authority, revise "Cause" definitions with notice and cure processes, and add pro-rata vesting provisions for RSUs and equity awards. These are compensatory arrangements that would affect investor assessment of executive retention costs and incentive structures.
View raw filing on EDGAR →The filing discloses new employment agreements for three named executives (CEO Ryan Melsert, CFO Alejandro Flores Arteaga, and COO Steven Wu) effective July 1, 2026, specifying annual salaries, performance-based bonuses, RSU grants, and stock option awards. The Compensation Committee approved these arrangements under Section 16b-3. This is a classic executive compensation disclosure under Item 5.02(e), distinct from appointment or departure since these executives are continuing in their existing roles under revised compensation terms.
View raw filing on EDGAR →The Board authorized and stockholders approved an amendment to the Veritone 2023 Equity Incentive Plan increasing authorized shares by 3,000,000 for equity compensation purposes, expanding the company's capacity to grant equity awards to executives and employees.
View raw filing on EDGAR →The filing discloses Board-approved amendments to the Employment Agreements of the CEO and CFO, including material changes to both cash compensation (base salary increase from $31,000 to $37,800 monthly for Mr. Iglesias, two-month performance bonus, and bonus timing flexibility) and equity compensation (replacement of annual equity incentives with Series B Preferred Share grants subject to shareholder approval). This is a classic Item 5.02(e) compensatory arrangement disclosure affecting named executives.
View raw filing on EDGAR →While Dr. Anderson's retirement was previously disclosed (April 10, 2026), the principal new disclosure here is the consulting agreement entered into on July 6, 2026, which establishes compensatory arrangements including hourly fees ($216/hour for up to 10 hours/week), continued vesting of restricted stock awards, and conditional equity acceleration (25% automatic vesting upon completion of the full term). This is a compensatory arrangement for a named executive officer, fitting the exec_compensation category under Item 5.02(e), though the departure itself was already known.
View raw filing on EDGAR →This announcement discloses the grant of 1,326,736 RSUs to 107 employees under the 2026 Share Scheme on July 9, 2026, representing 0.31% of issued shares. The disclosure details vesting schedules, clawback mechanisms, and the compensatory purpose of aligning employee interests with the Group's long-term development. This is a material equity compensation arrangement subject to Hong Kong Listing Rules Rule 17.06A-C, requiring board announcement and disclosure of the terms and conditions of the awards.
View raw filing on EDGAR →The 6-K discloses receipt of share-based incentive awards by nine senior managers and officers (including CFO Marco Wirén) on 2026-07-09, totaling approximately 860,000 shares transferred from treasury without consideration to settle equity-based incentive plan commitments. This constitutes executive compensation disclosure under the equity-grant category, material to investors assessing management incentive alignment and dilution.
View raw filing on EDGAR →The disclosure centers on compensatory arrangements approved by the Human Capital and Compensation Committee for Laura Cockrill following her appointment as CFO. The material elements are: base salary increase to $650,000, Annual Bonus Plan target increase to 175% of base salary, LTI target increase to 300% of base salary, and a $1,000,000 retention bonus paid in three tranches through 2029. While the section mentions her prior appointment as CFO (which occurred June 22, 2026 and was previously reported), the substantive new disclosure here is the compensation adjustment and retention bonus arrangement, making this an exec_compensation event.
View raw filing on EDGAR →The filing discloses new employment agreements with three executive officers (Jung, Knox, and Rubenstein) effective July 7, 2026, detailing compensatory arrangements including severance provisions, change-of-control protections, equity vesting acceleration, cash bonus targets (up to 75% for Knox, 35% for Rubenstein), and base salary adjustments (Rubenstein's salary set at $325,000). While Item 5.02 encompasses departures and appointments, the substantive disclosure centers on modifications to compensation structures and severance arrangements rather than personnel changes, making this a compensation event material to investor assessment of executive cost and retention risk.
View raw filing on EDGAR →The disclosure centers on an amended and restated employment agreement with CEO Adam Metz that modifies his compensatory arrangements, specifically increasing his target annual bonus from $1,225,000 to $1,300,000 and establishing new bonus measurement terms tied to a six-month performance period. While the agreement also addresses his continued service as CEO, the substantive changes disclosed are compensation-focused, making this an exec_compensation event rather than an appointment.
View raw filing on EDGAR →The disclosure centers on special equity awards (500,000 RSUs, 100,000 RSUs, and 400,000 stock options) granted to the Executive Chairman on July 6, 2026, approved by the Compensation Committee. This is a compensatory arrangement for a named executive officer, not a departure or appointment, making exec_compensation the appropriate classification under Item 5.02(e).
View raw filing on EDGAR →The filing discloses entry into a new Supplemental Executive Retirement Plan for Lyle Cunningham, superseding a prior plan from April 2022. The disclosure details compensatory arrangements including monthly pension benefits ($12,500 upon normal retirement), early termination benefits, change-in-control benefits, and disability/death benefits—all hallmarks of executive compensation disclosure under Item 5.02(e). This is a material modification to the executive's deferred compensation package.
View raw filing on EDGAR →The Board ratified a new Company-wide annual incentive program (AIP) and approved specific fiscal 2026 AIP award payouts for named executive officers, including $602,784 for CEO Mark A. Smith, $345,621 for CFO Neal S. Shah, and $378,197 for COO Scott Honan. This is a compensatory arrangement disclosure under Item 5.02(e), establishing both a formal incentive plan framework and concrete awards to senior executives.
View raw filing on EDGAR →The Compensation Committee approved cash retention awards for two named executive officers—Vincent J. O'Neill (CFO) and Kathleen A. Morgan (Chief Legal Officer)—totaling approximately $1.28 million, with tranches tied to the pending Rocket Lab merger closing and specific vesting conditions and severance provisions.
View raw filing on EDGAR →This exhibit is a formal Remuneration Policy for Administrators of Itaú Unibanco Holding S.A., approved by the Board of Directors on 06/25/2026. It comprehensively discloses compensatory arrangements for directors and officers, including fixed and variable remuneration structures, equity-based compensation requirements (minimum 70% of variable remuneration in shares deferred over three years), malus and clawback mechanisms, and ESG-linked performance criteria. The policy also incorporates a Clawback Policy compliant with NYSE Rule 10D-1 and SEC Section 10D. This is a material disclosure of executive compensation governance and structure that would affect investor assessment of the company's compensation practices and risk management alignment.
View raw filing on EDGAR →The disclosure centers on compensatory arrangements for David J. Enholm, the CFO: a voluntary salary reduction from $75,000 to $62,400, a waiver of accrued PTO rights, and a grant of 80,000 RSUs (40,000 vesting immediately and 40,000 upon Form 10-K filing) under the 2022 Equity Incentive Plan. While the salary reduction is voluntary, the RSU grant is material consideration for that reduction and continued service, making this fundamentally a compensation arrangement disclosure under Item 5.02(e).
View raw filing on EDGAR →